OVERVIEW

Cardio-Renal Syndromes in Diabetes 2024 is organized by Columbia University and will be held on Oct 25, 2024.

Learning Objectives:
Identify the prevalence and pathogenesis of cardiorenal and atherosclerotic cardiovascular complications.
Discuss current guidelines for optimal management of diabetic patients to prevent and treat cardiorenal and atherosclerotic complications.
Examine the causes of inflammation in atherosclerosis.
Target the mechanism of action and indications/contraindications of GLP1-agonists and SGLT2-inhibitors.
Examine the modern therapies for Diabetic Kidney disease.
Recognize the importance of multidisciplinary care in the management of heart disease in patients with diabetes, including collaboration between • • • • primary care providers, endocrinologists, cardiologists, and other healthcare professionals.
Identify up to date effective treatment options for managing heart disease in patients with diabetes, including pharmacologic interventions such as beta-blockers, ACE inhibitors, mineralocorticoid antagonists, statins, GLP1-agonists and SGLT2 inhibitors.

KEY DATES

Event Start Date
25 Oct, 2024
Event Start Date
Event End Date
25 Oct, 2024
Event End Date
Credits

 Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.

Physicians (ACCME) Credit Designation Statement
Amedco LLC designates this live virtual activity for a maximum of 4.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

PAs may claim a maximum of 4.50 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Nurse Practitioners

The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Maximum of 4.50 hours.


 

  • 4.5 AMA PRA Category 1 Credits™
  • 4.5 Hours
  • TARGET AUDIENCE

    Nephrologists

    SPECIALITIES

    Endocrinology, Metabolism and DiabetesNephrology

    RELATED CONFERENCES & LIVE WEBINARS

    May 16, 2022 - Nov 30, 2026 | Webcast

    State required course for Connecticut
    5 AMA PRA Category 1 Credits™
    ...
    More actions
    US$50.05

    Mar 28, 2022 - Nov 30, 2026 | Webcast

    State required course for Texas
    24 AMA PRA Category 1 Credits™
    ...
    More actions
    US$450

    May 16, 2022 - Nov 30, 2026 | Webcast

    State required course for Arizona
    40.25 AMA PRA Category 1 Credits™
    ...
    More actions
    US$740